INVO
Income statement / Annual
Last year (2023), INVO Bioscience, Inc.'s total revenue was $3.02 M,
an increase of 267.38% from the previous year.
In 2023, INVO Bioscience, Inc.'s net income was -$8.03 M.
See INVO Bioscience, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$3.02 M
|
$822,196.00
|
$4.16 M
|
$1.04 M
|
$1.48 M
|
$494,375.00
|
$282,145.00
|
$50,901.00
|
$11,689.00
|
$16,588.00
|
| Cost of Revenue |
$1.93 M |
$331,523.00 |
$145,052.00 |
$88,760.00 |
$139,670.00 |
$90,367.00 |
$51,954.00 |
$15,094.00 |
$7,810.00 |
$7,682.00 |
| Gross Profit |
$1.09 M |
$490,673.00 |
$4.02 M |
$948,526.00 |
$1.34 M |
$404,008.00 |
$230,191.00 |
$35,807.00 |
$3,879.00 |
$8,906.00 |
| Gross Profit Ratio |
0.36 |
0.6 |
0.97 |
0.91 |
0.91 |
0.82 |
0.82 |
0.7 |
0.33 |
0.54 |
| Research and Development
Expenses |
$165,945.00
|
$544,043.00
|
$216,430.00
|
$398,426.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$7.49 M
|
$10.57 M
|
$9.02 M
|
$6.07 M
|
$3.13 M
|
$3.04 M
|
$870,612.00
|
$2.15 M
|
$598,953.00
|
$1.69 M
|
| Other Expenses |
$200,894.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$3.04 M |
$870,612.00 |
$2.15 M |
$598,953.00 |
$1.69 M |
| Operating Expenses |
$7.85 M |
$11.12 M |
$9.23 M |
$6.46 M |
$3.13 M |
$3.04 M |
$870,612.00 |
$2.15 M |
$598,953.00 |
$1.69 M |
| Cost And Expenses |
$9.79 M |
$11.45 M |
$9.38 M |
$6.55 M |
$3.27 M |
$3.13 M |
$922,566.00 |
$2.16 M |
$606,763.00 |
$1.70 M |
| Interest Income |
$0.00 |
$308.00 |
$3,657.00 |
$4,190.00 |
$379,019.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$925,909.00 |
$59,445.00 |
$1.27 M |
$2.84 M |
$379,019.00 |
$442,031.00 |
$20,873.00 |
$13,838.00 |
$32,018.00 |
$51,896.00 |
| Depreciation &
Amortization |
$200,894.00
|
$306,319.00
|
$166,083.00
|
$34,481.00
|
$25,346.00
|
$5,190.00
|
$2,810.00
|
$1,878.00
|
$5,633.00
|
$10,531.00
|
| EBITDA |
-$6.88 M
|
-$10.52 M
|
-$5.22 M
|
-$5.48 M
|
-$1.76 M
|
-$2.63 M
|
-$678,480.00
|
-$2.11 M
|
-$4.92 M
|
-$1.67 M
|
| EBITDA Ratio |
-2.19 |
-13.17 |
-1.29 |
-5.31 |
-1.21 |
-5.32 |
-2.26 |
-41.42 |
-50.43 |
-100.68 |
| Operating Income Ratio
|
-2.24
|
-12.92
|
-1.25
|
-5.32
|
-1.21
|
-5.33
|
-2.27
|
-41.46
|
-50.91
|
-101.31
|
| Total Other
Income/Expenses Net |
-$1.24 M
|
-$263,158.00
|
-$1.43 M
|
-$2.83 M
|
-$379,019.00
|
-$442,031.00
|
-$61,742.00
|
-$13,838.00
|
-$4.36 M
|
-$51,896.00
|
| Income Before Tax |
-$8.01 M |
-$10.89 M |
-$6.65 M |
-$8.35 M |
-$2.17 M |
-$3.08 M |
-$702,163.00 |
-$2.12 M |
-$4.96 M |
-$1.73 M |
| Income Before Tax Ratio
|
-2.65
|
-13.24
|
-1.6
|
-8.05
|
-1.46
|
-6.22
|
-2.49
|
-41.73
|
-424.27
|
-104.44
|
| Income Tax Expense |
$27,786.00 |
$2,872.00 |
$4,764.00 |
$36.00 |
$433.00 |
-$155,951.00 |
$20,873.00 |
$0.00 |
$32,018.00 |
$0.00 |
| Net Income |
-$8.03 M |
-$10.89 M |
-$6.65 M |
-$8.35 M |
-$2.17 M |
-$3.08 M |
-$702,163.00 |
-$2.12 M |
-$4.96 M |
-$1.73 M |
| Net Income Ratio |
-2.66 |
-13.25 |
-1.6 |
-8.05 |
-1.46 |
-6.22 |
-2.49 |
-41.73 |
-424.27 |
-104.44 |
| EPS |
-5.13 |
-17.97 |
-12.52 |
-30.41 |
-8.93 |
-12.76 |
-3.16 |
-9.67 |
-23.15 |
-13.35 |
| EPS Diluted |
-5.13 |
-17.97 |
-12.52 |
-30.41 |
-8.93 |
-12.76 |
-3.16 |
-9.67 |
-23.15 |
-13.35 |
| Weighted Average Shares
Out |
$1.57 M
|
$606,130.00
|
$531,620.00
|
$274,486.00
|
$242,743.00
|
$241,082.00
|
$222,081.00
|
$219,682.00
|
$214,196.00
|
$129,806.00
|
| Weighted Average Shares
Out Diluted |
$1.57 M
|
$606,130.00
|
$531,620.00
|
$274,486.00
|
$242,743.00
|
$241,082.00
|
$222,081.00
|
$219,682.00
|
$214,196.00
|
$129,806.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
